Reflecting on 30 years of miRNA biology in malignant hematology: current challenges and future directions

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial for regulating hematopoiesis, including stem cell maintenance and cell differentiation.
• Dysregulation of miRNAs is linked to hematologic malignancies, notably acute myeloid leukemia (AML).
• Clinical translation of miRNA research is impeded by methodological inconsistencies and model limitations.

Purpose of the Study:

• To discuss the complexities of miRNA-mRNA interactions and their regulation.
• To highlight limitations in current research methodologies and advocate for advanced, physiologically relevant systems.
• To explore emerging miRNA-targeted therapeutic strategies for hematologic disorders.

Main Methods:

• Review of current literature on miRNA biology and function in hematopoiesis.
• Discussion of advanced technologies: hematopoietic organoids, single-cell and spatial transcriptomics, CRISPR-based assays.
• Analysis of miRNA-targeted therapeutics, including lipid nanoparticle delivery and anti-miRs.

Main Results:

• miRNA activity is influenced by context-dependent interactions, strand selection, isomiRs, RNA-binding proteins, and epitranscriptomic modifications.
• Commonly used bulk sequencing and reductionist models have significant limitations.
• Emerging technologies offer more physiologically relevant systems for studying miRNA function.

Conclusions:

• Integrating advanced technologies and standardized methodologies is essential for robust miRNA research in hematology.
• This approach will uncover novel regulatory mechanisms and therapeutic vulnerabilities in hematologic malignancies.
• The findings pave the way for improved diagnostic, prognostic, and therapeutic applications in hematology.